Aurinia Pharmaceuticals (AUPH) Other Operating Expenses (2019 - 2026)
Aurinia Pharmaceuticals' (AUPH) quarterly Other Operating Expenses came in at -$279000.0 in Q1 2026, up 93.7% YoY from -$144036.7 in Q1 2025, and down 105.5% on a QoQ basis from $5.1 million in Q4 2025.
Aurinia Pharmaceuticals (AUPH) Other Operating Expenses (2019 - 2026) Analysis & Trends
Aurinia Pharmaceuticals (AUPH) has 8 years of Other Operating Expenses data on file, last reported at -$279000.0 in Q1 2026.
- Quarterly Other Operating Expenses rose 93.7% year-over-year to -$279000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.4 million (down 27.88% YoY) and the FY2025 annual result came in at -$9.5 million, down 319.23% from the prior year.
- Other Operating Expenses declined to -$279000.0 in Q1 2026, from $5.1 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $5.1 million in Q4 2025 to a low of -$9.2 million in Q2 2025.
- A 5-year average of -$724588.2 and a median of -$279000.0 in 2026 frame the typical range for Other Operating Expenses.
- Annual changes were most pronounced in 2024 — Other Operating Expenses surged 1522.41% — and 2025, when it tumbled 3288.28%.
- Tracing AUPH's Other Operating Expenses over 5 years: stood at $2.2 million in 2022, then slumped by 518.16% to -$9.1 million in 2023, then surged by 149.66% to $4.5 million in 2024, then grew by 12.61% to $5.1 million in 2025, then plunged by 105.5% to -$279000.0 in 2026.
- The last three Other Operating Expenses figures came in at -$279000.0 (Q1 2026), $5.1 million (Q4 2025), and -$929000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Aurinia Pharmaceuticals | 2.06 Bn | 1.61 Bn | 76.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.23 Mn |
| Mar 31, 2026 | -279,000.00 |
| Dec 31, 2025 | 5.07 Mn |
| Sep 30, 2025 | -929,000.00 |
| Jun 30, 2025 | -9.25 Mn |
| Mar 31, 2025 | -4.43 Mn |
| Dec 31, 2024 | 4.51 Mn |
| Sep 30, 2024 | -4.57 Mn |
| Jun 30, 2024 | 290,000.00 |
| Mar 31, 2024 | 4.13 Mn |
| Dec 31, 2023 | -9.07 Mn |
| Sep 30, 2023 | -2.65 Mn |
| Jun 30, 2023 | 3.63 Mn |
| Mar 31, 2023 | -290,000.00 |
| Dec 31, 2022 | 2.17 Mn |
| Sep 30, 2022 | 311,000.00 |
| Jun 30, 2022 | 476,000.00 |
| Mar 31, 2022 | -1.43 Mn |
| Dec 31, 2021 | 285,000.00 |
| Sep 30, 2021 | -55,000.00 |